Biotechnology in Europe
Summary
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
- The European biotechnology market recorded revenues of $226.4 billion in 2024, representing a compound annual growth rate (CAGR) of 4.2% between 2019 and 2024.
- The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $157.6 billion, equivalent to 69.6% of the market's overall value.
- The European biotechnology market is experiencing unprecedented growth, fueled by a surge in equity financing and venture capital investments. According to the UK Bio Industry Association (BIA), in 2024, the UK biotech and healthcare market saw an annual increase of 94% in equity financing, raising around GBP3.5 billion ($4.4 million).
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts
- What was the size of the Europe biotechnology market by value in 2024?
- What will be the size of the Europe biotechnology market in 2029?
- What factors are affecting the strength of competition in the Europe biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Europe's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the key players?
- 7.2. What strategies do the key players follow?
- 7.3. What have been the most recent market developments?
- 8 Company Profiles
- 8.1. AstraZeneca Plc
- 8.2. Novartis AG
- 8.3. Bayer AG
- 8.4. Novo Nordisk AS
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Europe biotechnology industry value: $ million, 2019-24
- Table 2: Europe biotechnology industry category segmentation: % share, by value, 2019-24
- Table 3: Europe biotechnology industry category segmentation: $ million, 2019-24
- Table 4: Europe biotechnology industry geography segmentation: $ million, 2024
- Table 5: Europe biotechnology industry value forecast: $ million, 2024-29
- Table 6: AstraZeneca Plc: Key Facts
- Table 7: AstraZeneca Plc: Annual Financial Ratios
- Table 8: AstraZeneca Plc: Key Employees
- Table 9: Novartis AG: Key Facts
- Table 10: Novartis AG: Annual Financial Ratios
- Table 11: Novartis AG: Key Employees
- Table 12: Bayer AG: Key Facts
- Table 13: Bayer AG: Annual Financial Ratios
- Table 14: Bayer AG: Key Employees
- Table 15: Bayer AG: Key Employees Continued
- Table 16: Bayer AG: Key Employees Continued
- Table 17: Novo Nordisk AS: Key Facts
- Table 18: Novo Nordisk AS: Annual Financial Ratios
- Table 19: Novo Nordisk AS: Key Employees
- Table 20: Europe Size of Population (Million), 2019-24
- Table 21: Europe Real GDP (Constant 2010 Prices, $ Billion), 2019-24
- Table 22: Europe GDP (Current Prices, $ Billion), 2019-24
- Table 23: Europe Inflation, 2019-24
- Table 24: Europe Consumer Price Index (Absolute), 2019-24
- Table 25: Europe Exchange Rate, 2019-24
- List of Figures
- Figure 1: Europe biotechnology industry value: $ million, 2019-24
- Figure 2: Europe biotechnology industry category segmentation: $ million, 2019-24
- Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2024
- Figure 4: Europe biotechnology industry value forecast: $ million, 2024-29
- Figure 5: Forces driving competition in the biotechnology industry in Europe, 2024
- Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2024
- Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2024
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2024
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2024
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook